Pathogenesis of Cryptococcus neoformans

Erin E. McClelland, Arturo Casadevall, Helene C. Eisenman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cryptococcus neoformans (Cn) is a fungal pathogen, commonly found in urban environments (Tampieri, 2006) that primarily affects immunocompromised individuals through inhalation of spores. In healthy individuals Cn infection is usually cleared, or can remain in a latent form for prolonged periods of time. However, in individuals with impaired immune function, the infection may spread to the central nervous system (CNS), causing life-threatening meningitis (Casadevall & Perfect, 1998; Hull & Heitman, 2002). Thus, the disease is relatively common in AIDS patients. A recent study shows that the prevalence of cryptococcosis has declined with the increasing availability of highly active retroviral therapy (HAART) to treat HIV (Lortholary et al., 2006; Mirza et al., 2003). However, the disease continues to be a problem for those with limited access to HAART, especially in the developing world (Banerjee et al., 2001; Marques et al., 2000). Another group of individuals who are susceptible to cryptococcosis are organ transplant recipients receiving immunosuppressive therapy (Husain et al., 2001; Vilchez et al., 2002). However, cryptococcosis is not limited to immunocompromised persons, as shown by the recent outbreak in Vancouver among healthy individuals (Hoang et al., 2004).

Original languageEnglish (US)
Title of host publicationNew Insights in Medical Mycology
PublisherSpringer Netherlands
Pages131-157
Number of pages27
ISBN (Print)9781402063978, 9781402063961
DOIs
StatePublished - 2007
Externally publishedYes

Fingerprint

Cryptococcosis
Cryptococcus neoformans
Highly Active Antiretroviral Therapy
Immunosuppressive Agents
Infection
Spores
Meningitis
Inhalation
Disease Outbreaks
Acquired Immunodeficiency Syndrome
Central Nervous System
Cross-Sectional Studies
HIV
Transplants
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

McClelland, E. E., Casadevall, A., & Eisenman, H. C. (2007). Pathogenesis of Cryptococcus neoformans. In New Insights in Medical Mycology (pp. 131-157). Springer Netherlands. https://doi.org/10.1007/978-1-4020-6397-8_6

Pathogenesis of Cryptococcus neoformans. / McClelland, Erin E.; Casadevall, Arturo; Eisenman, Helene C.

New Insights in Medical Mycology. Springer Netherlands, 2007. p. 131-157.

Research output: Chapter in Book/Report/Conference proceedingChapter

McClelland, EE, Casadevall, A & Eisenman, HC 2007, Pathogenesis of Cryptococcus neoformans. in New Insights in Medical Mycology. Springer Netherlands, pp. 131-157. https://doi.org/10.1007/978-1-4020-6397-8_6
McClelland EE, Casadevall A, Eisenman HC. Pathogenesis of Cryptococcus neoformans. In New Insights in Medical Mycology. Springer Netherlands. 2007. p. 131-157 https://doi.org/10.1007/978-1-4020-6397-8_6
McClelland, Erin E. ; Casadevall, Arturo ; Eisenman, Helene C. / Pathogenesis of Cryptococcus neoformans. New Insights in Medical Mycology. Springer Netherlands, 2007. pp. 131-157
@inbook{4a1491dc5ecf4147a60ccb2a0fc423b2,
title = "Pathogenesis of Cryptococcus neoformans",
abstract = "Cryptococcus neoformans (Cn) is a fungal pathogen, commonly found in urban environments (Tampieri, 2006) that primarily affects immunocompromised individuals through inhalation of spores. In healthy individuals Cn infection is usually cleared, or can remain in a latent form for prolonged periods of time. However, in individuals with impaired immune function, the infection may spread to the central nervous system (CNS), causing life-threatening meningitis (Casadevall & Perfect, 1998; Hull & Heitman, 2002). Thus, the disease is relatively common in AIDS patients. A recent study shows that the prevalence of cryptococcosis has declined with the increasing availability of highly active retroviral therapy (HAART) to treat HIV (Lortholary et al., 2006; Mirza et al., 2003). However, the disease continues to be a problem for those with limited access to HAART, especially in the developing world (Banerjee et al., 2001; Marques et al., 2000). Another group of individuals who are susceptible to cryptococcosis are organ transplant recipients receiving immunosuppressive therapy (Husain et al., 2001; Vilchez et al., 2002). However, cryptococcosis is not limited to immunocompromised persons, as shown by the recent outbreak in Vancouver among healthy individuals (Hoang et al., 2004).",
author = "McClelland, {Erin E.} and Arturo Casadevall and Eisenman, {Helene C.}",
year = "2007",
doi = "10.1007/978-1-4020-6397-8_6",
language = "English (US)",
isbn = "9781402063978",
pages = "131--157",
booktitle = "New Insights in Medical Mycology",
publisher = "Springer Netherlands",

}

TY - CHAP

T1 - Pathogenesis of Cryptococcus neoformans

AU - McClelland, Erin E.

AU - Casadevall, Arturo

AU - Eisenman, Helene C.

PY - 2007

Y1 - 2007

N2 - Cryptococcus neoformans (Cn) is a fungal pathogen, commonly found in urban environments (Tampieri, 2006) that primarily affects immunocompromised individuals through inhalation of spores. In healthy individuals Cn infection is usually cleared, or can remain in a latent form for prolonged periods of time. However, in individuals with impaired immune function, the infection may spread to the central nervous system (CNS), causing life-threatening meningitis (Casadevall & Perfect, 1998; Hull & Heitman, 2002). Thus, the disease is relatively common in AIDS patients. A recent study shows that the prevalence of cryptococcosis has declined with the increasing availability of highly active retroviral therapy (HAART) to treat HIV (Lortholary et al., 2006; Mirza et al., 2003). However, the disease continues to be a problem for those with limited access to HAART, especially in the developing world (Banerjee et al., 2001; Marques et al., 2000). Another group of individuals who are susceptible to cryptococcosis are organ transplant recipients receiving immunosuppressive therapy (Husain et al., 2001; Vilchez et al., 2002). However, cryptococcosis is not limited to immunocompromised persons, as shown by the recent outbreak in Vancouver among healthy individuals (Hoang et al., 2004).

AB - Cryptococcus neoformans (Cn) is a fungal pathogen, commonly found in urban environments (Tampieri, 2006) that primarily affects immunocompromised individuals through inhalation of spores. In healthy individuals Cn infection is usually cleared, or can remain in a latent form for prolonged periods of time. However, in individuals with impaired immune function, the infection may spread to the central nervous system (CNS), causing life-threatening meningitis (Casadevall & Perfect, 1998; Hull & Heitman, 2002). Thus, the disease is relatively common in AIDS patients. A recent study shows that the prevalence of cryptococcosis has declined with the increasing availability of highly active retroviral therapy (HAART) to treat HIV (Lortholary et al., 2006; Mirza et al., 2003). However, the disease continues to be a problem for those with limited access to HAART, especially in the developing world (Banerjee et al., 2001; Marques et al., 2000). Another group of individuals who are susceptible to cryptococcosis are organ transplant recipients receiving immunosuppressive therapy (Husain et al., 2001; Vilchez et al., 2002). However, cryptococcosis is not limited to immunocompromised persons, as shown by the recent outbreak in Vancouver among healthy individuals (Hoang et al., 2004).

UR - http://www.scopus.com/inward/record.url?scp=79955715147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955715147&partnerID=8YFLogxK

U2 - 10.1007/978-1-4020-6397-8_6

DO - 10.1007/978-1-4020-6397-8_6

M3 - Chapter

SN - 9781402063978

SN - 9781402063961

SP - 131

EP - 157

BT - New Insights in Medical Mycology

PB - Springer Netherlands

ER -